Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.

Geurts JM, Janssen RG, van Greevenbroek MM, van der Kallen CJ, Cantor RM, Bu X, Aouizerat BE, Allayee H, Rotter JI, de Bruin TW.

Hum Mol Genet. 2000 Sep 1;9(14):2067-74.

2.

Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q.

Aouizerat BE, Allayee H, Cantor RM, Dallinga-Thie GM, Lanning CD, de Bruin TW, Lusis AJ, Rotter JI.

Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2730-6.

3.

Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia.

Xu CF, Talmud P, Schuster H, Houlston R, Miller G, Humphries S.

Clin Genet. 1994 Dec;46(6):385-97.

PMID:
7889654
4.

Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia.

Tahvanainen E, Pajukanta P, Porkka K, Nieminen S, Ikävalko L, Nuotio I, Taskinen MR, Peltonen L, Ehnholm C.

Arterioscler Thromb Vasc Biol. 1998 Nov;18(11):1810-7.

5.

Two newly identified SNPs in the APO AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemia.

Groenendijk M, Cantor RM, Funke H, Dallinga-Thie GM.

Eur J Clin Invest. 2001 Oct;31(10):852-9.

PMID:
11737222
6.

Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.

Dallinga-Thie GM, van Linde-Sibenius Trip M, Rotter JI, Cantor RM, Bu X, Lusis AJ, de Bruin TW.

J Clin Invest. 1997 Mar 1;99(5):953-61.

7.

Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.

Eurlings PM, van der Kallen CJ, Geurts JM, Flavell DM, de Bruin TW.

Mol Genet Metab. 2002 Dec;77(4):274-81.

PMID:
12468272
8.

Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1.

Huertas-Vazquez A, Aguilar-Salinas C, Lusis AJ, Cantor RM, Canizales-Quinteros S, Lee JC, Mariana-Nuñez L, Riba-Ramirez RM, Jokiaho A, Tusie-Luna T, Pajukanta P.

Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1985-91. Epub 2005 Jun 23.

9.

Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study.

Coon H, Myers RH, Borecki IB, Arnett DK, Hunt SC, Province MA, Djousse L, Leppert MF.

Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2275-80.

10.

Unraveling the complex genetics of familial combined hyperlipidemia.

Suviolahti E, Lilja HE, Pajukanta P.

Ann Med. 2006;38(5):337-51. Review.

PMID:
16938803
11.

Association analysis of bone mineral density and single nucleotide polymorphisms in two candidate genes on chromosome 1p36.

Spotila LD, Rodriguez H, Koch M, Tenenhouse HS, Tenenhouse A, Li H, Devoto M.

Calcif Tissue Int. 2003 Aug;73(2):140-6.

PMID:
14565595
12.

Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia.

Jarvik GP, Beaty TH, Gallagher PR, Coates PM, Cortner JA.

Genet Epidemiol. 1993;10(4):257-70.

PMID:
8224806
13.

A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

Aouizerat BE, Allayee H, Cantor RM, Davis RC, Lanning CD, Wen PZ, Dallinga-Thie GM, de Bruin TW, Rotter JI, Lusis AJ.

Am J Hum Genet. 1999 Aug;65(2):397-412.

14.

No association with hypertension of CLCNKB and TNFRSF1B polymorphisms at a hypertension locus on chromosome 1p36.

Speirs HJ, Wang WY, Benjafield AV, Morris BJ.

J Hypertens. 2005 Aug;23(8):1491-6.

PMID:
16003175
15.

Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: evidence for genetic heterogeneity.

Dieudé P, Petit E, Cailleau-Moindrault S, Osorio J, Pierlot C, Martinez M, Fauré S, Alibert O, Lasbleiz S, De Toma C, Bardin T, Prum B, Cornélis F; European Consortium on Rheumatoid Arthritis Families.

Arthritis Rheum. 2002 Aug;46(8):2039-44.

16.

New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia.

Groenendijk M, Cantor RM, De Bruin TW, Dallinga-Thie GM.

J Lipid Res. 2001 Feb;42(2):188-94.

17.
18.

Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families.

Huertas-Vázquez A, del Rincón JP, Canizales-Quinteros S, Riba L, Vega-Hernández G, Ramírez-Jiménez S, Aurón-Gómez M, Gómez-Pérez FJ, Aguilar-Salinas CA, Tusié-Luna MT.

Ann Hum Genet. 2004 Sep;68(Pt 5):419-27.

19.

Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study.

Vendrell J, Broch M, Fernandez-Real JM, Gutiérrez C, Simón I, Megia A, Gallart L, Ricart W, Richart C.

Diabet Med. 2005 Apr;22(4):387-92.

PMID:
15787661
20.

No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families.

Pajukanta P, Porkka KV, Antikainen M, Taskinen MR, Perola M, Murtomäki-Repo S, Ehnholm S, Nuotio I, Suurinkeroinen L, Lahdenkari AT, Syvänen AC, Viikari JS, Ehnholm C, Peltonen L.

Arterioscler Thromb Vasc Biol. 1997 May;17(5):841-50.

Items per page

Supplemental Content

Write to the Help Desk